MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.

Zhang S, Wang M, Li Q, Zhu P.

Open source

DOI
10.3233/cbm-170620
Published
2017-12-01
Container
Cancer Biomark
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3233/cbm-170620,
  title = {MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.},
  author = {Zhang S and  Wang M and  Li Q and  Zhu P.},
  year = {2017},
  journal = {Cancer Biomark},
  doi = {10.3233/cbm-170620},
  url = {https://doi.org/10.3233/cbm-170620}
}

RIS

TY  - JOUR
TI  - MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
AU  - Zhang S
AU  -  Wang M
AU  -  Li Q
AU  -  Zhu P.
PY  - 2017
JO  - Cancer Biomark
DO  - 10.3233/cbm-170620
UR  - https://doi.org/10.3233/cbm-170620
ER  - 

APA

S, Z., M, W., Q, L., & P., Z. (2017). MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.. Cancer Biomark. https://doi.org/10.3233/cbm-170620

Source records